Application of the PET ligand [C-11]ORM-13070 to examine receptor occupancy by the alpha(2C)-adrenoceptor antagonist ORM-12741: translational validation of target engagement in rat and human brain
| dc.contributor.author | Shahid Mohammed | |
| dc.contributor.author | Rinne Juha O | |
| dc.contributor.author | Scheinin Mika | |
| dc.contributor.author | Virta Jere | |
| dc.contributor.author | Marjamäki Päivi | |
| dc.contributor.author | Solin Olof | |
| dc.contributor.author | Arponen Eveliina | |
| dc.contributor.author | Sallinen Jukka | |
| dc.contributor.author | Kuokkanen Katja | |
| dc.contributor.author | Rouru Juha | |
| dc.contributor.organization | fi=MediCity|en=MediCity| | |
| dc.contributor.organization | fi=PET-keskus|en=Turku PET Centre| | |
| dc.contributor.organization | fi=biolääketieteen laitos|en=Institute of Biomedicine| | |
| dc.contributor.organization | fi=kemian laitos|en=Department of Chemistry| | |
| dc.contributor.organization | fi=kliininen fysiologia ja isotooppilääketiede|en=Clinical Physiology and Isotope Medicine| | |
| dc.contributor.organization | fi=kliininen laitos|en=Department of Clinical Medicine| | |
| dc.contributor.organization | fi=tyks, vsshp|en=tyks, varha| | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.14646305228 | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.27622076134 | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.61334543354 | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.77952289591 | |
| dc.contributor.organization-code | 2607322 | |
| dc.contributor.organization-code | 2609810 | |
| dc.converis.publication-id | 51368765 | |
| dc.converis.url | https://research.utu.fi/converis/portal/Publication/51368765 | |
| dc.date.accessioned | 2022-10-28T13:41:15Z | |
| dc.date.available | 2022-10-28T13:41:15Z | |
| dc.description.abstract | <b>Background</b><div>Availability of the α<sub>2C</sub>-adrenoceptor (α2C-AR) positron emission tomography (PET) tracer, [<sup>11</sup>C]ORM-13070, and the α2C-AR antagonist ORM-12741 allows probing of the roles of this G-protein coupled receptor subtype in brain function, both in healthy humans and in patients with various brain disorders. This translational study employed [11C]ORM-13070 autoradiography and PET to determine α2C-AR occupancy by ORM-12741 in rat and human brain, respectively.</div><div><br /></div><div><b>Results</b></div><div>ORM-12741 has high affinity (K<sub>i</sub>: 0.08 nM) and potent antagonist activity (K<sub>b</sub>: 0.04 nM) as well as selectivity (K<sub>i</sub> estimates for the humanα2A-AR and α2B-AR were 8.3 nM and 0.8 nM, respectively) for the human α2C-AR subtype. [11C]ORM-13070 had highest uptake in the basal ganglia of rat and human brain. Pretreatment with ORM-12741 inhibited [11C]ORM-13070 binding in rat striatum in a time- and dose-dependent manner at 10 and 50 µg/kg (s.c.) with an EC<sub>50</sub> estimate of 1.42 ng/mL in rat plasma, corresponding to protein-free drug concentration of 0.23 nM. In the living human brain, time- and dose-related α2C-AR occupancy was detected with EC50 estimates of 24 ng/mL and 31 ng/mL for the caudate nucleus and putamen, respectively, corresponding to protein-free concentrations in plasma of 0.07 nM and 0.1 nM. Modelling-based maximum α2C-AR occupancy estimates were 63% and 52% in the caudate nucleus and the putamen, respectively.</div><div><br /></div><div><b>Conclusions</b></div><div>ORM-12741 is a selective α2C-AR antagonist which penetrates the rat and human brain to occupy α2C-ARs in a manner consistent with its receptor pharmacology.</div><div><br /></div><div>Trial registration number and date of registration: ClinicalTrial.cov NCT00829907. Registered 11 December 2008. https://clinicaltrials.gov/.</div> | |
| dc.identifier.eissn | 2191-219X | |
| dc.identifier.jour-issn | 2191-219X | |
| dc.identifier.olddbid | 183624 | |
| dc.identifier.oldhandle | 10024/166718 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/34204 | |
| dc.identifier.urn | URN:NBN:fi-fe2021042822930 | |
| dc.language.iso | en | |
| dc.okm.affiliatedauthor | Rinne, Juha | |
| dc.okm.affiliatedauthor | Scheinin, Mika | |
| dc.okm.affiliatedauthor | Virta, Jere | |
| dc.okm.affiliatedauthor | Marjamäki, Päivi | |
| dc.okm.affiliatedauthor | Solin, Olof | |
| dc.okm.affiliatedauthor | Arponen, Eveliina | |
| dc.okm.affiliatedauthor | Dataimport, MediCity | |
| dc.okm.affiliatedauthor | Dataimport, tyks, vsshp | |
| dc.okm.discipline | 3126 Surgery, anesthesiology, intensive care, radiology | en_GB |
| dc.okm.discipline | 3126 Kirurgia, anestesiologia, tehohoito, radiologia | fi_FI |
| dc.okm.internationalcopublication | international co-publication | |
| dc.okm.internationality | International publication | |
| dc.okm.type | A1 ScientificArticle | |
| dc.publisher | SPRINGER | |
| dc.publisher.country | Germany | en_GB |
| dc.publisher.country | Saksa | fi_FI |
| dc.publisher.country-code | DE | |
| dc.relation.articlenumber | ARTN 152 | |
| dc.relation.doi | 10.1186/s13550-020-00741-y | |
| dc.relation.ispartofjournal | EJNMMI Research | |
| dc.relation.issue | 1 | |
| dc.relation.volume | 10 | |
| dc.source.identifier | https://www.utupub.fi/handle/10024/166718 | |
| dc.title | Application of the PET ligand [C-11]ORM-13070 to examine receptor occupancy by the alpha(2C)-adrenoceptor antagonist ORM-12741: translational validation of target engagement in rat and human brain | |
| dc.year.issued | 2020 |
Tiedostot
1 - 1 / 1
Ladataan...
- Name:
- ShahidEtAl2020ApplicationOfThePETLigand.pdf
- Size:
- 1.29 MB
- Format:
- Adobe Portable Document Format
- Description:
- Publisher's PDF